"I believe the only way the BOD would do a dividend would be to benefit Schwartz or some other large stockholder."

So, if indeed CJ is employed directly or indirectly by a company which is ostensibly owned by Eric Swartz (e.g. Roswell) is there not a conflict of interest and should CJ not recuse himself from any and all related discussions and votes which might imbue benefit to Mr. Swartz?

If so, does he? Or does he rely on CF/GF to provide the necessary "majority" on such matters?

http://investing.businessweek.com/research/stocks/private/person.asp?personId=1101862&privcapId=31149532&previousCapId=20991737&previousTitle=CRYOPORT%20INC

Mr. Eric S. Swartz is a Principal at Roswell Capital Partners, LLC. Mr. Swartz has been with the firm for past 16 years. Mr. Swartz also founded Swartz Investments, LLC in 1993 and serves as its President. He has 24 years of experience in the securities business. Mr. Swartz has been involved in leading and structuring over 130 private equity transactions in small-cap public companies.
At the time 20,000,000 PTSC common stock warrants were issued in March 2003 the following was published:
"Eric Swartz, principal in Swartz Private Equity who has been a major investor in the company, said, "We continue to believe in PTSC's technology and have decided to lock up and unreserve the warrants to show our continued commitment to be a long term investor."

Mr. Carlton M. Johnson, Jr. is a Securities Counsel at the Roswell Capital Partners, LLC. Mr. Johnson joined Roswell Capital Partners on April 1996 and his responsibilities include general corporate, securities law, business litigation, and corporate governance. Mr. Johnson has been the Legal Counsel at Swartz Investments, LLC, since June 1996.
Mr. Johnson has been Director of Patriot Scientific Corp., since August 5, 2001. He is also a Patriot Scientific Co-Chair to the holding company for intellectual property licensing and enforcement.

Roswell Capital Partners, LLC is a private equity firm specializing in growth capital investments in small-cap publicly traded securities. The firm focuses on investing in growing OTC BB and NASDAQ Small Cap issuers. It seeks to invest between $2 million and $5 million per tranche with companies seeking a long-term funding partner and a strategic partner to support its growth. Roswell Capital Partners, LLC is based in Alpharetta, Georgia.